Alert: Major Price Advance (12/20/23)-Catalyst Biosciences Inc (NASDAQ: CBIO).


Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 10.9% on 12/20/23. The shares closed at $28.70. NORMAL trading volume accompanied the advance. The stock has risen 42.6% during the last week and has been exceptionally strong relative to the market over the last nine months.


Current PriceTarget Research Rating

CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.

Catalyst Biosciences is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.